about
Model-specific selection of molecular targets for heart failure gene therapyCardiac gene therapy: optimization of gene delivery techniques in vivo.Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.The Use of Gene Therapy for Ablation of Atrial Fibrillation.Gene targeting in ischemic heart disease and failure: translational and clinical studies.In vivo cardiac myosin binding protein C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein C null miceCurrent strategies for myocardial gene delivery.Herpesvirus-mediated delivery of a genetically encoded fluorescent Ca(2+) sensor to canine cardiomyocytes.MicroRNAs as a therapeutic target for cardiovascular diseasesCalcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.Advances in gene-based therapy for heart failure.Chronic heart failure: current evidence, challenges to therapy, and future directions.Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function.Gene- and cell-based bio-artificial pacemaker: what basic and translational lessons have we learned?Cardiac gene therapy: are we there yet?Gene Delivery for the Generation of Bioartificial Pacemaker.SERCA2a gene therapy for heart failure: ready for primetime?ERK1/2 pathway regulates coxsackie and adenovirus receptor expression in mouse cardiac stem cells.Gene therapy for cardiomyocytes, a heart beat away.Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.Intramyocardial injection of thioredoxin 2-expressing lentivirus alleviates myocardial ischemia-reperfusion injury in rats.
P2860
Q26823061-6598CB3A-27A2-4BA6-830D-4DB0EECCFDF0Q33832137-499E3D15-FF7E-44B9-A679-67BD066AB1DFQ34195822-2B73934B-E643-42CC-9A03-D3350E48F2DEQ36458906-FDA6355A-98C5-498D-A97F-505189B4B6CDQ36617570-B436B075-7CAC-4B19-88B2-9D34107A377BQ36882651-CB22FE77-4932-4D6F-8DC3-771A752BB9F8Q36931967-121DCC89-D6C2-4985-91D3-F05B3F6798CFQ37266791-16438936-8090-4978-8A75-E748E1D1E279Q37294704-6DBB5456-0978-40FE-B53D-17EF70798C71Q37364786-2E338BDC-2934-4C52-AB7B-05AD3772E29AQ37766138-7ADF1DF8-2C24-466B-81BC-C322C6BD893EQ37880858-4F3960B7-0B21-4C51-B20E-4CA94F72402CQ37989402-8776DE67-78B8-4E87-8A60-1B9FEF7A2451Q38016715-E8167D2F-B9C4-4913-8D60-8203A237721BQ38820937-15E3653C-2F9D-4D42-88DD-71FB672A8A59Q40445275-DF0BCB1A-859E-49C1-8A7C-94C2232344FCQ40910862-F0E4F702-0756-4F52-AF9B-4863EDAE60C8Q42119381-37DADBEB-0A23-4369-90F4-C80E8461B133Q45884822-36161E90-DE8C-4C78-BAE6-8C7316A648AEQ45886178-E7310CBF-8D53-4B75-A625-D2186EF4C455Q47135870-C664E42E-17E1-4615-9F55-2C2C37563A73
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Gene therapy in the treatment of heart failure.
@en
type
label
Gene therapy in the treatment of heart failure.
@en
prefLabel
Gene therapy in the treatment of heart failure.
@en
P2093
P2860
P1433
P1476
Gene therapy in the treatment of heart failure.
@en
P2093
Roger J Hajjar
Ryuichi Yoneyama
Yoshiaki Kawase
P2860
P356
10.1152/PHYSIOL.00037.2006
P577
2007-04-01T00:00:00Z